Table 1 Demographics of the study population
From: Multiple Mechanisms Support Oligoclonal T Cell Expansion in Rheumatoid Synovitis
% CD4+ T Cells Expressing IL-2R | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Patient | Age (years) | Sex | Disease Duration (months) | Treatmenta | RF | HLA | Source | Blood | Synovium |
CRB | 68 | M | 8 | NSAID | + | n.d.b | Fc | 9.2 | 12.6 |
DC | 68 | F | 240 | NSAID, DMARD | − | DRB1*0401/07 | F | 4.2 | 21.8 |
DMP | 53 | F | 84 | NSAID | + | DRB1*01/08 | T, F | 5.4 | 18.9 |
EK1 | 24 | F | 120 | NSAID, DMARD, Pred | + | DRB1*01/0401 | T | 6.8 | 5.4 |
EK2 | 54 | F | 24 | NSAID, DMARD, Pred | − | DRB1*01/13 | T | 1.3 | 5.7 |
HW | 62 | M | 132 | NSAID, DMARD | − | DRB1*04/13 | T | n.d. | n.d. |
JAB | 56 | M | 432 | NSAID | + | DRB1*0401/0404 | T, F | 6.9 | 17.9 |
JE | 54 | M | 408 | NSAID, Pred | − | DRB1*01/01 | T | 1.7 | 12.5 |
JH | 44 | M | 6 | NSAID, DMARD | + | DRB1*0401/07 | F | 6.2 | 10.2 |
KB | 23 | F | 2 | NSAID | − | DRB1*0401/13 | F | n.d. | n.d. |
LT | 68 | M | 240 | NSAID, Pred | + | DRB1*0401/0404 | T | 0.6 | 3.3 |
RC | 61 | M | 66 | NSAID, DMARD, Pred | + | DRB1*03/0404 | T | 1.4 | 6.2 |
RL | 68 | F | 60 | NSAID, DMARD | + | DRBl*01/03 | T | 0.9 | 7.4 |
RMB | 46 | M | 240 | NSAID | − | DRB1*01/0401 | T | n.d. | n.d. |